Literature DB >> 18021516

Quality of care in gout: from measurement to improvement.

T R Mikuls1.   

Abstract

Gout is a growing health problem, affecting approximately 7% of men and 3% of women over the age of 65 years. Although effective therapies for gout management exist, quality in gout care has been too frequently characterized as being "suboptimal." This review examines issues pertinent to quality of care in gouty arthritis with a focus on initial reports examining suboptimal care, subsequent efforts to develop quality of care indicators for gout management, more recently published evidence-based recommendations for gout diagnosis and treatment, and an ongoing international initiative to develop core outcome measures for acute and chronic gout. "If you can not measure it, you can not improve it" - Lord Kelvin.

Entities:  

Mesh:

Year:  2007        PMID: 18021516

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

1.  Quality of care in patients with gout: why is management suboptimal and what can be done about it?

Authors:  N Lawrence Edwards
Journal:  Curr Rheumatol Rep       Date:  2011-04       Impact factor: 4.592

2.  Gout: multinational gout guidelines: how do we move beyond 'déjà vu'?

Authors:  Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2013-09-17       Impact factor: 20.543

3.  Patients and providers view gout differently: a qualitative study.

Authors:  Leslie R Harrold; Kathleen M Mazor; Sarah Velten; Ira S Ockene; Robert A Yood
Journal:  Chronic Illn       Date:  2010-07-30

4.  Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China.

Authors:  Qian-Hua Li; Lie Dai; Zhao-Xia Li; Hai-Jun Liu; Chan-Juan Zou; Xia Ou-Yang; Meng Lu; Ting Li; Yan-Hua Li; Yin-Qian Mo; H Ralph Schumacher
Journal:  Clin Rheumatol       Date:  2013-07-16       Impact factor: 2.980

Review 5.  Gout. Novel therapies for treatment of gout and hyperuricemia.

Authors:  Robert Terkeltaub
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156

Review 6.  Update on gout: new therapeutic strategies and options.

Authors:  Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.